University of Wisconsin–Madison

A Dose Blind, Multi-Center, Extension Study to Determine the Long-Term Safety and Efficacy of Two Doses of BG00012 Monotherapy in Subjects With Relapsing-Remitting Multiple Sclerosis

February 2015 to January 2013

This project led by: Christopher Luzzio, MD